Summary Slide.png (71.21 kB)

Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-Marketing Surveillance

Download (71.21 kB)
figure
posted on 03.04.2018 by Masakazu Haneda, Takashi Kadowaki, Hiroshi Ito, Kazuyo Sasaki, Sonoe Hiraide, Manabu Ishii, Miyuki Matsukawa, Makoto Ueno

Article full text


The full text of this article can be found here. https://link.springer.com/article/10.1007/s13300-018-0416-2


Provide enhanced content for this article


If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com.


The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.


Other enhanced features include, but are not limited to:


• Slide decks

• Videos and animations

• Audio abstracts

• Audio slides

Funding

Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo Co, Ltd.

History

Exports